Myoclonus clinical trials
The registry lists 23 studies for Myoclonus across more than 10 countries. 7 are recruiting or about to start. Per ClinicalTrials.gov, last updated 2026-09-16.
Status
- Completed
- 10
- Recruiting
- 6
- Status unknown
- 3
- Terminated
- 2
- Active, not recruiting
- 1
- Not yet recruiting
- 1
Phase
- Phase 4
- 3
- Phase 1
- 3
- Phase 2
- 3
- Phase 3
- 2
Where
- United States
- 11
- Canada
- 2
- France
- 2
- Switzerland
- 1
- Austria
- 1
- United Kingdom
- 1
Who runs them
Boston Children's Hospital (3) · National Pediatric Neuroinflammation Organization, Inc. (2) · National Institute of Neurological Disorders and Stroke (NINDS) (2) · Tang-Du Hospital (2) · Institut Curie (1) · Autifony Therapeutics Limited (1) · Jean M. Tersak, M.D. (1) · Assistance Publique - Hôpitaux de Paris (1)
Studies
Recruiting first, then most recently updated. Showing 23 of 23 — search for more.
- Natural History of Glycosphingolipid Storage Disorders and Glycoprotein DisordersRecruitingNCT000299651 country
- A Retrospective Survey-based Multicenter Study to Delineate the Molecular and Phenotypic Spectrum of Epilepsy-dyskinesia SyndromesRecruitingNCT065856051 country
- Registry and Natural History Study for Progressive Myoclonus Epilepsy Type 1 (EPM1)RecruitingNCT065939511 country
- Clinical Validation of DystoniaNet Deep Learning Platform for Diagnosis of Isolated DystoniaRecruitingNCT05317390Not applicable1 country
- Registry and Natural History of Epilepsy-Dyskinesia SyndromesRecruitingNCT069677271 country
- Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at SanfordRecruitingNCT017931682 countries
- Thalamic Ventral Intermediate Electrical Stimulation for Refractory Familial Cortical Myoclonus with EpilepsyNot yet recruitingNCT06593444Not applicable
- High-Dose Ambroxol in Pediatric Type III Gaucher Disease (GD3)CompletedNCT07285369Not applicable1 country
- Safety, Blood Levels and Effects of AUT00201 in Patients With MEAKCompletedNCT05873062Phase 11 country
- Opsoclonus Myoclonus Syndrome/Dancing Eye Syndrome (OMS/DES) in Children With and Without Neuroblastoma (NBpos and NBneg)Opsoclonus Myoclonus Syndrome/Dancing Eye Syndrome (OMS/DES) in Children With and Without Neuroblastoma (NBpos and NBneg)CompletedNCT01868269Phase 37 countries
- The Link Between Clinical and Physiological Sleep Data and Health-related OutcomesActive, not recruitingNCT033833541 country
- Median Effective Dose of Remifentanil for the Prevention of Myoclonus Induced by Etomidate InjectionStatus unknownNCT05754762Not applicable
- Effect of Pretreatment of Lignocaine Versus Midazolam in Prevention of Etomidate Induced Myoclonus.CompletedNCT04921046Phase 4
- Use of Rituximab in Opsoclonus-Myoclonus in Children With NeuroblastomaTerminatedNCT00202930Phase 2
- Electrophysiological Characteristics and Anatomical Differentiation of Epileptic and Non-epileptic Myoclonus.CompletedNCT042354521 country
- Study of Cytokines in Children With Opsoclonus-Myoclonus SyndromeCompletedNCT008061821 country
- Effects and Mechanism of Pretreatment With Dexmedetomidine to Etomidate Induce MyoclonusStatus unknownNCT02518789Phase 4
- Efficacy Trial of Zonisamide for Myoclonus DystoniaCompletedNCT01806805Phase 31 country
- Effect of Pre-injection of Lidocaine on Myoclonus Induced by Induction With Etomidate in Elderly Patients During General AnesthesiaStatus unknownNCT02141737Phase 41 country
- Pilot Efficacy Study of T2000 in Myoclonus DystoniaTerminatedNCT00506012Phase 21 country
- Effectiveness of Rituximab in Pediatric OMS Patients.CompletedNCT00244361Phase 1/21 country
- Genotype/Phenotype Correlation of Movement Disorders and Other Neurological DiseasesCompletedNCT000016671 country
- Treatment of Cortical Myoclonus With Repetitive Transcranial Magnetic StimulationCompletedNCT00001663Phase 11 country